127 related articles for article (PubMed ID: 7833144)
1. Somatostatin receptor expression in lung cancer.
O'Byrne KJ; Halmos G; Pinski J; Groot K; Szepeshazi K; Schally AV; Carney DN
Eur J Cancer; 1994; 30A(11):1682-7. PubMed ID: 7833144
[TBL] [Abstract][Full Text] [Related]
2. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
3. Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.
O'Byrne KJ; Ennis JT; Freyne PJ; Clancy LJ; Prichard JS; Carney DN
Br J Cancer; 1994 Apr; 69(4):762-6. PubMed ID: 7908220
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma].
Hoefer M; Schmidt S; Welter J; Kirsch CM; Ukena D; Sybrecht GW
Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059
[TBL] [Abstract][Full Text] [Related]
5. Indium-111-DTPA-octreotide scintigraphy modulation by treatment with unlabelled somatostatin analogue in small-cell lung cancer.
Soresi E; Bombardieri E; Chiti A; Boffi R; Invernizzi G; Crippa F; Maffioli L
Tumori; 1995; 81(2):125-7. PubMed ID: 7778214
[TBL] [Abstract][Full Text] [Related]
6. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
Breeman WA; Hofland LJ; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Visser TJ; Lamberts SW
Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760
[TBL] [Abstract][Full Text] [Related]
7. Radiolabelled somatostatin analogue scintigraphy in oncology.
O'Byrne KJ; Carney DN
Anticancer Drugs; 1996 Jan; 7 Suppl 1():33-44. PubMed ID: 8822083
[TBL] [Abstract][Full Text] [Related]
8. Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma.
Kirsch CM; von Pawel J; Grau I; Tatsch K
Eur J Nucl Med; 1994 Dec; 21(12):1318-25. PubMed ID: 7875170
[TBL] [Abstract][Full Text] [Related]
9. High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69).
Taylor JE; Coy DH; Moreau JP
Life Sci; 1988; 43(5):421-7. PubMed ID: 2899828
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin and the lung.
O'Byrne KJ; Carney DN
Lung Cancer; 1993 Dec; 10(3-4):151-72. PubMed ID: 7915618
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin, its receptors and analogs, in lung cancer.
O'Byrne KJ; Schally AV; Thomas A; Carney DN; Steward WP
Chemotherapy; 2001; 47 Suppl 2():78-108. PubMed ID: 11275704
[TBL] [Abstract][Full Text] [Related]
12. Imaging of bronchial carcinoid tumours with indium-111 pentetreotide.
O'Byrne KJ; O'Hare NJ; Freyne PJ; Luke DA; Clancy LJ; Prichard JS; Carney DN
Thorax; 1994 Mar; 49(3):284-6. PubMed ID: 7911261
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
[TBL] [Abstract][Full Text] [Related]
14. Receptor scintigraphy of non-neuroendocrine cancers with In-111 pentetreotide.
Limouris GS; Rassidakis A; Kondi-Paphiti A; Triantafyllou N; Manetou A; Gennatas K; Vitoratos N; Gregoriou O; Stavraka A; Vlahos L
Hybridoma; 1997 Feb; 16(1):133-7. PubMed ID: 9085140
[TBL] [Abstract][Full Text] [Related]
15. 111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung.
Traub T; Petkov V; Ofluoglu S; Pangerl T; Raderer M; Fueger BJ; Schima W; Kurtaran A; Dudczak R; Virgolini I
J Nucl Med; 2001 Sep; 42(9):1309-15. PubMed ID: 11535718
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of (111)In labeled somatostatin analogs for targeted therapy of somatostatin receptor positive tumors.
Bernhardt P; Ahlman H; Nilsson O; Benjegård SA; Forssell-Aronsson E
Cancer Biother Radiopharm; 2003 Apr; 18(2):249-52. PubMed ID: 12804051
[No Abstract] [Full Text] [Related]
17. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors.
Reubi JC; Waser B; Sheppard M; Macaulay V
Int J Cancer; 1990 Feb; 45(2):269-74. PubMed ID: 1968052
[TBL] [Abstract][Full Text] [Related]
18. Treatment of transplanted tumor of lung adenocarcinoma A549 transfected by human somatostatin receptor subtype 2 (hsstr2) gene with 188Re-RC-160.
Zhao R; Yang W; Wang Z; Li G; Qin W; Wang J
Nucl Med Biol; 2010 Nov; 37(8):977-87. PubMed ID: 21055629
[TBL] [Abstract][Full Text] [Related]
19. Targeting peptides for pleural cavity tumor radiotherapy: specificity and dosimetry of Re-188-RC-160.
Zamora PO; Bender H; Knapp FF; Rhodes BA; Biersack HJ
Hybridoma; 1997 Feb; 16(1):85-91. PubMed ID: 9085134
[TBL] [Abstract][Full Text] [Related]
20. Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6.
Prévost G; Bourgeois Y; Mormont C; Lerrant Y; Veber N; Poupon MF; Thomas F
Life Sci; 1994; 55(2):155-62. PubMed ID: 8015359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
